SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-17-011794
Filing Date
2017-05-30
Accepted
2017-05-30 13:12:57
Documents
3
Effectiveness Date
2017-05-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A - NOTICE AND ACCESS CARD orex-defa14a_20170530.htm DEFA14A 35110
2 GRAPHIC g201705261753342391842.jpg GRAPHIC 114346
3 GRAPHIC g201705261753342071841.jpg GRAPHIC 124507
  Complete submission text file 0001564590-17-011794.txt   365426
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33415 | Film No.: 17876501
SIC: 2834 Pharmaceutical Preparations